Literature DB >> 26099670

FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.

Ujas Parikh1, Charles Marcus1, Rutuparna Sarangi1, Mehdi Taghipour1, Rathan M Subramaniam2.   

Abstract

Fludeoxyglucose F 18 ((18)F-FDG) PET/CT has not been shown to offer additional benefit in the initial diagnosis of pancreatic cancer, but studies show benefit of (18)F-FDG PET/CT in initial staging and patient prognosis. There is evidence for (18)F-FDG PET and (18)F-FDG PET/CT in staging and prognosis of cholangiocarcinoma and gallbladder cancer. (18)F-FDG PET/CT has shown promise in staging liver malignancies by detecting extrahepatic metastasis. There is evidence supporting the ability of PET/CT in predicting prognosis in patients with hepatocellular carcinoma. Evidence is evolving for the role of (18)F-FDGPET/CT in predicting prognosis and survival in patients with colorectal liver metastasis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (18)F-FDG PET/CT; Hepatocellular carcinoma; Pancreatic cancer

Mesh：

Substances：

Year:  2015        PMID： 26099670     DOI： 10.1016/j.cpet.2015.03.001

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  10 in total

1.  Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma.

Authors:  Allison N Lau; Zhaoqi Li; Laura V Danai; Anna M Westermark; Alicia M Darnell; Raphael Ferreira; Vasilena Gocheva; Sharanya Sivanand; Evan C Lien; Kiera M Sapp; Jared R Mayers; Giulia Biffi; Christopher R Chin; Shawn M Davidson; David A Tuveson; Tyler Jacks; Nicholas J Matheson; Omer Yilmaz; Matthew G Vander Heiden
Journal:  Elife       Date:  2020-07-10       Impact factor: 8.140

2.  The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas.

Authors:  Esra Arslan; Tamer Aksoy; Nevra Dursun; Rıza Umar Gürsu; Mert Mahsuni Sevinç; Tevfik Fikret Çermik
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

Review 3.  [Ductal adenocarcinoma and unusual differential diagnosis].

Authors:  P Haage; C A Schwartz; C Scharwächter
Journal:  Radiologe       Date:  2016-04       Impact factor: 0.635

4.  FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.

Authors:  Shixiong Lei; Jiandong Yang; Chong Chen; Jiachen Sun; Liu Yang; Haili Tang; Tao Yang; An Chen; Huadong Zhao; Yan Li; Xilin Du
Journal:  J Exp Clin Cancer Res       Date:  2016-05-13

5.  Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.

Authors:  Yazan Abuodeh; Arash O Naghavi; Kamran A Ahmed; Puja S Venkat; Youngchul Kim; Bela Kis; Junsung Choi; Benjamin Biebel; Jennifer Sweeney; Daniel A Anaya; Richard Kim; Mokenge Malafa; Jessica M Frakes; Sarah E Hoffe; Ghassan El-Haddad
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

6.  Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma.

Authors:  Paul Blanc-Durand; Axel Van Der Gucht; Adrien Depeursinge; Niklaus Schaefer; Mario Jreige; Marie Nicod-Lalonde; Marina Silva-Monteiro; John O Prior; Alban Denys
Journal:  Oncotarget       Date:  2017-12-19

Review 7.  Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.

Authors:  Serena De Matteis; Andrea Ragusa; Giorgia Marisi; Stefania De Domenico; Andrea Casadei Gardini; Massimiliano Bonafè; Anna Maria Giudetti
Journal:  Oxid Med Cell Longev       Date:  2018-11-04       Impact factor: 6.543

8.  Preoperative imaging for colorectal liver metastases: a nationwide population-based study.

Authors:  A K E Elfrink; M Pool; L R van der Werf; E Marra; M C Burgmans; M R Meijerink; M den Dulk; P B van den Boezem; W W Te Riele; G A Patijn; M W J M Wouters; W K G Leclercq; M S L Liem; P D Gobardhan; C I Buis; K F D Kuhlmann; C Verhoef; M G Besselink; D J Grünhagen; J M Klaase; N F M Kok
Journal:  BJS Open       Date:  2020-05-06

Review 9.  The clinical application of 18F-FDG PET/CT in pancreatic cancer: a narrative review.

Authors:  Yongzhu Pu; Chun Wang; Sheng Zhao; Ran Xie; Lei Zhao; Kun Li; Conghui Yang; Rui Zhang; Yadong Tian; Lixian Tan; Jindan Li; Shujuan Li; Long Chen; Hua Sun
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

Review 10.  Complex roles of nicotinamide N-methyltransferase in cancer progression.

Authors:  Weixuan Wang; Changmei Yang; Tianxiang Wang; Haiteng Deng
Journal:  Cell Death Dis       Date:  2022-03-25       Impact factor: 9.685
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.